4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and selective p70S6 kinase inhibitors

This publication has 11 references indexed in Scilit:

• Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities
  The Journal of Pharmacology and Experimental Therapeutics, 2007
• Discovery of Aminofurazan-azabenzimidazoles as Inhibitors of Rho-Kinase with High Kinase Selectivity and Antihypertensive Activity
  Journal of Medicinal Chemistry, 2006
• (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2005
• (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Further optimisation as highly potent and selective MSK-1-inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2005
• Restraining PI3K: mTOR signalling goes back to the membrane
  Trends in Biochemical Sciences, 2005
• Synthesis and in Vitro Characterization of 1-(4-Aminofurazan-3-yl)-5-dialkylaminomethyl-1H-[1,2,3]triazole-4-carboxylic Acid Derivatives. A New Class of Selective GSK-3 Inhibitors
  Journal of Medicinal Chemistry, 2003
• Genomic analysis of the eukaryotic protein kinase superfamily: a perspective
  Genome Biology, 2003
• Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling
  Genes & Development, 2002
• The S6 kinase Signaling Pathway In The Control of Development and Growth
  Biological Research, 2002
• Synthesis and properties of 4-amino-3-cyanofurazan
  Chemistry of Heterocyclic Compounds, 1994